Antiinfektiøse pyrimidiner og anvendelser heraf

The present invention relates to a crystalline form of N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide or a crystalline form of a salt of N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)m...

Full description

Saved in:
Bibliographic Details
Main Authors LONGENECKER, KENTON L, HAIGHT, ANTHONY R, LIU, DACHUN, DONNER, PAMELA L, RANDOLPH, JOHN T, ROCKWAY, TODD W, FRANCZYK II, THADDEUS S, GAO, YI, FLENTGE, CHARLES, A, KATI, WARREN M, HUTCHINSON, DOUGLAS K, KRUEGER, ALLAN C, BETEBENNER, DAVID A, MARING, CLARENCE J, DEGOEY, DAVID A, WAGNER, ROLF, LOU, XIAOCHUN, CHEN, SHUANG, ZHANG, GEOFF G Z, PRATT, JOHN K, STEWART, KENT D, HENGEVELD, JOHN E, BARNES, DAVID M, MOTTER, CHRISTOPHER E, KOTECKI, BRIAN J, LIU, YAYA
Format Patent
LanguageDanish
Published 01.12.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a crystalline form of N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide or a crystalline form of a salt of N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide as well as pharmaceutical compositions comprising said crystalline forms, therapeutic uses of said crystalline forms and processes for making said crystalline forms.
Bibliography:Application Number: DK20110171399T